The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity.
Open accessAbstract
Detection of new ligand-defective mutations of apolipopro- tein B (apoB) will enable identification of sequences in- volved in binding to the LDL receptor.Genomic DNA from patients attending a lipid clinic was screened by singlestrand conformation polymorphism analysis for novel muta- tions in the putative LDL receptor-binding domain of apoB-100.A 46-yr-old woman of Celtic and Native Ameri- can ancestry with primary hypercholesterolemia (total cho- lesterol [TC] 343 mg/dl; LDL cholesterol [LDL-C] 241 mg/ dl) and pronounced peripheral vascular disease was found to be heterozygous for a novel Arg3531-Cys mutation, caused by a C-T transition at nucleotide 10800.One unrelated 59yr-old man of Italian ancestry was found with the same mutation after screening 1,560 individuals.He had coronary heart disease, a TC of 310 mg/dl, and an LDL-C of 212 mg/ dl.A total of eight individuals were found with the defect in the families of the two patients.They had an age-and sex-adjusted TC of 240±14 mg/dl and LDL-C of 169±+10 mg/dl.This compares with eight unaffected family members with age-and sex-adjusted TC of 185±12 mg/dl and LDL- C of 124±+12 mg/dl.In a dual-label fibroblast binding assay, LDL from the eight subjects with the mutation had an affin- ity for the LDL receptor that was 63% that of control LDL.LDL from eight unaffected family members had an affinity of 91%.By way of comparison, LDL from six patients het- erozygous for the Arg3500-Gln mutation had an affinity of 36%.The percentage mass ratio of the defective Cys3531 LDL to normal LDL was 59:41, as determined using the mAb MB19 and dynamic laser light scattering.Thus, the defec- tive LDL had accumulated in the plasma of these patients.Using this mass ratio, it was calculated that the defective Cys353, LDL particles bound with 27% of normal affinity.Deduced haplotypes using 10 apoB gene markers showed
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.
Hixson, J., & Vernier, D. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43176-1 · Cited by 2,933
Cited by
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
Juma, S., Imrhan, V., Vijayagopal, P., & Prasad, C. (2014) · Lifestyle Genomics · doi:10.1159/000370213 · Cited by 1,891
Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence Review
Austin, M. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh236 · Cited by 657
Clinical Genetic Testing for Familial Hypercholesterolemia
Sturm, A. C., Knowles, J. W., Gidding, S. S., Ahmad, Z. S., Ahmed, C. D., Ballantyne, C. M., Baum, S. J., Bourbon, M., Carrié, A., Cuchel, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.044 · Cited by 615
Mechanisms of disease: genetic causes of familial hypercholesterolemia
Soutar, A. K., & Naoumova, R. P. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0836 · Cited by 608
Human cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C. S., Salen, G., Shefer, S., BATTA, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15387 · Cited by 468
Self-citationHuman cholesterol 7α-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype
Pullinger, C. R., Eng, C., Salen, G., Shefer, S., Batta, A. K., Erickson, S. K., Verhagen, A., Rivera, C. R., Mulvihill, S. J., Malloy, M. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215387 · Cited by 457
Self-citationAdvancing human genetics research and drug discovery through exome sequencing of the UK Biobank
Szustakowski, J. D., Balasubramanian, S., Kvikstad, E., Khalid, S., Bronson, P. G., Sasson, A., Wong, E., Liu, D., Wade Davis, J., Haefliger, C., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00885-0 · Cited by 401
Benn, M. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.004 · Cited by 119
Olsson, U., Camejo, G., Hurt-Camejo, E., Elfsber, K., Wiklund, O., & Bondjers, G. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.1.149 · Cited by 94
Baum, S. J., Toth, P. P., Underberg, J. A., Jellinger, P., Ross, J., & Wilemon, K. (2017) · Clinical Cardiology · doi:10.1002/clc.22713 · Cited by 88
“Mutations that cause a reduced affinity of apoB for LDLR also result in decreased LDL clearance and constitute a cause of FH.14 Additional heterogeneity in the hereditary basis for FH became apparent.”
BackgroundInfluentialRelation of Increased Prebeta-1 High-Density Lipoprotein Levels to Risk of Coronary Heart Disease
Guey, L. T., Pullinger, C. R., Ishida, B. Y., O'Connor, P. M., Zellner, C., Francone, O. L., Laramie, J. M., Naya-Vigne, J. M., Siradze, K. A., Deedwania, P., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.054 · Cited by 70
Self-citationStructure of apolipoprotein B100 bound to the low-density lipoprotein receptor
Reimund, M., Dearborn, A. D., Graziano, G., Lei, H., Ciancone, A. M., Kumar, A., Holewinski, R., Neufeld, E. B., O’Reilly, F. J., Remaley, A. T., et al. (2025) · Nature · doi:10.1038/s41586-024-08223-0 · Cited by 63
A novel indel variant in LDLR responsible for familial hypercholesterolemia in a Chinese family
Shu, H., Chi, J., Li, J., Zhang, W., Lv, W., Wang, J., Deng, Y., Hou, X., & Wang, Y. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189316 · Cited by 10
Metadata
- Authors
- Pullinger, C. R., Hennessy, L. K., Chatterton, J. E., Liu, W., Love, J. A., Mendel, C. M., Frost, P. H., Malloy, M. J., Schumaker, V. N., & Kane, J. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-03-01
- Volume
- 95
- Issue
- 3
- Pages
- 1225-1234
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2102926989
- Cited by
- 200
- References
- 1
- FWCI
- 16.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.